Cash flow Croda International Plc

Equities

CRDA

GB00BJFFLV09

Specialty Chemicals

Real-time Estimate Cboe Europe Other stock markets 13:10:34 10/02/2026 GMT			5-day change	1st Jan Change
3,081.00 ^GBX	+5.30%		+14.52%	+15.29%

09:47am	BofA cuts Anglo American; LBBW cuts BT Group	AN
09:32am	FTSE 100 falls as BP slide outweighs AstraZeneca	AN

fbf4860595e7c1a5e4a.8q3Gzd2rnZfM1wTWsq5DO2HRrygYN_WlWkLgLdjeFKE.v8SHp7T-5fyp53Sh_94kVSWz43gpfqCWYwOPWo-uX-CWx7X-i_jb2vyUUQ

Published financial data: CRODA INTERNATIONAL PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.39B	1.89B	2.09B	1.69B	1.63B
Total Revenues	1.39B	1.89B	2.09B	1.69B	1.63B
Cost of Goods Sold, Total	758M	951M	1.1B	964M	894M
Gross Profit	632M	939M	986M	730M	734M
Selling General & Admin Expenses, Total	332M	500M	538M	477M	502M
Other Operating Expenses, Total	332M	500M	538M	477M	502M
Operating Income	300M	439M	447M	253M	232M
Interest Expense, Total	-18.3M	-22.1M	-24.1M	-26M	-31M
Interest And Investment Income	500K	1.5M	2.7M	9.4M	6.9M
Net Interest Expenses	-17.8M	-20.6M	-21.4M	-16.6M	-24.1M
Other Non Operating Income (Expenses)	-1.5M	-2.5M	-	-	-
EBT, Excl. Unusual Items	281M	416M	426M	236M	208M
Merger & Related Restructuring Charges	-11.7M	-1.5M	-	-	-
Gain (Loss) On Sale Of Assets	-	-	356M	-	-
Other Unusual Items	-	-3.3M	-1.7M	-	-
EBT, Incl. Unusual Items	270M	412M	780M	236M	208M
Income Tax Expense	67.9M	88.7M	127M	64.2M	48.2M
Earnings From Continuing Operations	202M	323M	653M	172M	160M
Net Income to Company	202M	323M	653M	172M	160M
Minority Interest	-	-2M	-4M	-1.1M	-1.1M
Net Income - (IS)	202M	321M	649M	171M	158M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	202M	321M	649M	171M	158M
Net Income to Common Excl. Extra Items	202M	321M	649M	171M	158M
Per Share Items
Net EPS - Basic	1.55	2.3	4.66	1.22	1.14
Basic EPS - Continuing Operations	1.55	2.3	4.66	1.22	1.14
Basic Weighted Average Shares Outstanding	130M	140M	139M	140M	140M
Net EPS - Diluted	1.55	2.3	4.65	1.22	1.14
Diluted EPS - Continuing Operations	1.55	2.3	4.65	1.22	1.14
Diluted Weighted Average Shares Outstanding	130M	140M	140M	140M	140M
Normalized Basic EPS	1.35	1.85	1.88	1.05	0.92
Normalized Diluted EPS	1.35	1.85	1.88	1.05	0.92
Dividend Per Share	0.91	1	1.08	1.09	1.1
Payout Ratio	57.49	41.3	22.24	88.13	96.03
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	370M	502M	516M	323M	347M
EBITA	314M	439M	447M	254M	270M
EBIT	300M	439M	447M	253M	232M
EBITDAR	371M	504M	517M	324M	349M
Effective Tax Rate - (Ratio)	25.19	21.56	16.24	27.17	23.2
Current Domestic Taxes	13.2M	11.5M	28.1M	-1.5M	-800K
Current Foreign Taxes	52.1M	95M	100M	62.1M	62M
Total Current Taxes	65.3M	106M	128M	60.6M	61.2M
Total Deferred Taxes	2.6M	-17.8M	-1.4M	3.6M	-13M
Normalized Net Income	176M	258M	262M	147M	129M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	17.1M	19.9M	19.9M	22.8M	28.6M
Non-Cash Pension Expense	23.9M	13.5M	9.3M	3.9M	4.8M
Supplemental Operating Expense Items
Selling and Marketing Expenses	71.7M	93M	102M	77.2M	79.2M
General and Administrative Expenses	259M	406M	-	405M	427M
Research And Development Expense From Footnotes	46M	74.5M	81.8M	80.3M	81.4M
Net Rental Expense, Total	1M	1.4M	1M	1.2M	1.2M
Imputed Operating Lease Interest Expense	191K	269K	248K	376K	422K
Imputed Operating Lease Depreciation	809K	1.13M	752K	824K	778K
Stock-Based Comp., Other (Total)	13.6M	41.3M	-11M	-4.2M	5M
Total Stock-Based Compensation	13.6M	41.3M	-11M	-4.2M	5M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	106M	113M	321M	172M	167M
Total Cash And Short Term Investments	106M	113M	321M	172M	167M
Accounts Receivable, Total	238M	277M	315M	318M	277M
Other Receivables	41.6M	45.9M	47.1M	65.8M	57.5M
Total Receivables	280M	323M	362M	384M	334M
Inventory	303M	443M	464M	341M	368M
Prepaid Expenses	9.8M	14.6M	14.1M	11.9M	15.1M
Total Current Assets	699M	894M	1.16B	909M	884M
Gross Property Plant And Equipment	1.56B	1.7B	1.56B	1.68B	1.77B
Accumulated Depreciation	-577M	-624M	-500M	-544M	-599M
Net Property Plant And Equipment	981M	1.08B	1.06B	1.13B	1.17B
Long-term Investments	5.2M	3.3M	3.4M	1.9M	1.9M
Goodwill	867M	852M	845M	938M	900M
Other Intangibles, Total	445M	420M	409M	471M	411M
Deferred Tax Assets Long-Term	14.5M	13.5M	10.3M	14.4M	14.7M
Other Long-Term Assets, Total	17.6M	35.3M	123M	114M	130M
Total Assets	3.03B	3.29B	3.61B	3.58B	3.51B
Liabilities
Accounts Payable, Total	97.8M	133M	121M	126M	127M
Accrued Expenses, Total	83.8M	132M	131M	80.9M	102M
Short-term Borrowings	28.7M	18.5M	39M	22.3M	25.1M
Current Portion of Long-Term Debt	20.4M	32.4M	82.9M	14.4M	9.9M
Current Portion of Leases	10.7M	12.2M	12.9M	13.7M	13.2M
Current Income Taxes Payable	48.7M	49M	43.8M	21.4M	20.8M
Other Current Liabilities	55.3M	82.1M	56.9M	41.7M	38.3M
Total Current Liabilities	345M	460M	488M	320M	336M
Long-Term Debt	776M	795M	402M	588M	580M
Long-Term Leases	71M	78.3M	79.2M	71.3M	70.7M
Pension & Other Post Retirement Benefits	49.9M	27.4M	23.1M	26.8M	25.7M
Deferred Tax Liability Non Current	160M	151M	173M	193M	181M
Other Non Current Liabilities	31M	15.9M	16M	11.6M	18.4M
Total Liabilities	1.43B	1.53B	1.18B	1.21B	1.21B
Preferred Stock Non Redeemable	1.1M	1.1M	-	-	-
Total Preferred Equity	1.1M	1.1M	-	-	-
Common Stock, Total	15.1M	15.1M	15.1M	15.1M	15.1M
Additional Paid In Capital	708M	708M	708M	708M	708M
Retained Earnings	843M	1.07B	1.65B	1.64B	1.66B
Comprehensive Income and Other	19.3M	-43.8M	47.1M	-10.3M	-100M
Total Common Equity	1.58B	1.75B	2.42B	2.35B	2.28B
Minority Interest	9.3M	12.8M	15.5M	15.6M	14.4M
Total Equity	1.6B	1.77B	2.43B	2.37B	2.3B
Total Liabilities And Equity	3.03B	3.29B	3.61B	3.58B	3.51B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	140M	140M	140M	140M	140M
ECS Total Common Shares Outstanding	140M	140M	140M	140M	140M
Book Value / Share	11.36	12.56	17.3	16.85	16.35
Tangible Book Value	273M	480M	1.16B	944M	972M
Tangible Book Value Per Share	1.96	3.44	8.32	6.76	6.96
Total Debt	907M	936M	616M	710M	699M
Net Debt	800M	823M	295M	538M	532M
Debt Equivalent of Unfunded Proj. Benefit Obligation	17.2M	-21.4M	-111M	-99.8M	-116M
Debt Equivalent Oper. Leases	8M	11.2M	8M	9.6M	9.6M
Minority Interest, Total (Incl. Fin. Div)	9.3M	12.8M	15.5M	15.6M	14.4M
Equity Method Investments, Total	1.8M	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	63.9M	122M	136M	98.3M	88.6M
Inventories - Work In Process, Total	39.8M	56M	45.8M	35.6M	44.9M
Inventories - Finished Goods, Total	199M	265M	282M	207M	234M
Land - (BS)	257M	297M	305M	320M	343M
Machinery, Total	1.2B	1.28B	1.12B	1.22B	1.28B
Full Time Employees	5.68K	6.14K	5.82K	5.85K	6.03K
Accumulated Allowance for Doubtful Accounts (Supple)	2.5M	2.9M	5.8M	6.8M	6.6M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	202M	321M	649M	171M	158M
Depreciation & Amortization - CF	66.1M	76.3M	83.4M	85.2M	93.5M
Amortization of Goodwill and Intangible Assets - (CF)	13.7M	0	300K	700K	38.2M
Depreciation & Amortization, Total	79.8M	76.3M	83.7M	85.9M	132M
Amortization of Deferred Charges, Total - (CF)	2M	2.7M	2.7M	3.6M	4.1M
(Gain) Loss From Sale Of Asset	-	5.8M	200K	200K	600K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	1.5M	-
Asset Writedown & Restructuring Costs	1.4M	1.1M	42.2M	22M	-
(Income) Loss On Equity Investments - (CF)	1.1M	700K	-	-	-
Stock-Based Compensation (CF)	4.1M	29.1M	-11M	-4.2M	5M
Other Operating Activities, Total	4.3M	13.7M	-325M	28.4M	-1.4M
Change In Accounts Receivable	-15.6M	-53.2M	-43.3M	-19M	21.3M
Change In Inventories	-7M	-141M	-98.1M	118M	-39.3M
Change In Accounts Payable	15.3M	91.6M	7.6M	-69.7M	38.9M
Cash from Operations	287M	348M	308M	338M	319M
Capital Expenditure	-115M	-153M	-141M	-180M	-178M
Sale of Property, Plant, and Equipment	200K	200K	1.7M	4M	900K
Cash Acquisitions	-868M	-58.1M	-	-204M	-
Divestitures	-	-	584M	-	-
Sale (Purchase) of Intangible assets	-6.2M	-5.7M	-11.2M	-8.6M	-3.4M
Investment in Marketable and Equity Securities, Total	-1.5M	-	-	-	-
Other Investing Activities, Total	-1.2M	400K	-8.3M	-20.5M	41.8M
Cash from Investing	-992M	-216M	425M	-410M	-139M
Long-Term Debt Issued, Total	439M	320M	233M	336M	440M
Total Debt Issued	439M	320M	233M	336M	440M
Long-Term Debt Repaid, Total	-209M	-297M	-632M	-228M	-467M
Total Debt Repaid	-209M	-297M	-632M	-228M	-467M
Issuance of Common Stock	616M	-	-	-	-
Repurchase of Common Stock	-6.9M	-2.4M	-7.3M	-9.8M	-1.8M
Common Dividends Paid	-116M	-132M	-144M	-151M	-152M
Preferred Dividends Paid	-100K	-100K	-	-	-
Common & Preferred Stock Dividends Paid	-116M	-132M	-144M	-151M	-152M
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-	-900K	-1.4M	-	-2.1M
Cash from Financing	722M	-113M	-552M	-52.4M	-183M
Foreign Exchange Rate Adjustments	-2.8M	-2.4M	6.8M	-6.7M	-6.2M
Net Change in Cash	14.7M	16.5M	187M	-131M	-8.5M
Supplemental Items
Cash Interest Paid	17.5M	19.8M	23.2M	24.2M	28.5M
Cash Income Tax Paid (Refund)	70.7M	112M	131M	69.3M	55.9M
Levered Free Cash Flow	110M	145M	84.68M	57.81M	123M
Unlevered Free Cash Flow	122M	159M	99.74M	74.06M	142M
Change In Net Working Capital	40.3M	77.2M	103M	-19.7M	-38M
Net Debt Issued / Repaid	230M	23.2M	-399M	108M	-26.5M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.63	8.69	8.09	4.4	4.09
Return on Total Capital	9.39	10.55	9.72	5.16	4.77
Return On Equity %	16.37	19.21	31.13	7.17	6.84
Return on Common Equity	16.49	19.23	31.16	7.17	6.84
Margin Analysis
Gross Profit Margin %	45.46	49.69	47.17	43.08	45.08
SG&A Margin	23.85	26.43	25.77	28.16	30.83
EBITDA Margin %	26.59	26.59	24.7	19.08	21.34
EBITA Margin %	22.6	23.25	21.41	14.97	16.59
EBIT Margin %	21.61	23.25	21.4	14.92	14.24
Income From Continuing Operations Margin %	14.5	17.08	31.27	10.16	9.8
Net Income Margin %	14.5	16.98	31.08	10.09	9.74
Net Avail. For Common Margin %	14.5	16.98	31.08	10.09	9.74
Normalized Net Income Margin	12.64	13.66	12.54	8.65	7.91
Levered Free Cash Flow Margin	7.93	7.68	4.05	3.41	7.53
Unlevered Free Cash Flow Margin	8.75	8.42	4.77	4.37	8.72
Asset Turnover
Asset Turnover	0.57	0.6	0.61	0.47	0.46
Fixed Assets Turnover	1.52	1.84	1.95	1.55	1.42
Receivables Turnover (Average Receivables)	6.71	7.33	7.06	5.36	5.47
Inventory Turnover (Average Inventory)	2.65	2.55	2.43	2.4	2.52
Short Term Liquidity
Current Ratio	2.02	1.94	2.38	2.84	2.63
Quick Ratio	1.12	0.95	1.4	1.74	1.49
Operating Cash Flow to Current Liabilities	0.83	0.76	0.63	1.05	0.95
Days Sales Outstanding (Average Receivables)	54.55	49.83	51.71	68.13	66.87
Days Outstanding Inventory (Average Inventory)	137.94	143.13	149.97	152.36	145.12
Average Days Payable Outstanding	37.34	38.64	41.23	53.49	50.18
Cash Conversion Cycle (Average Days)	155.14	154.32	160.45	167	161.81
Long Term Solvency
Total Debt/Equity	56.86	53	25.33	29.99	30.44
Total Debt / Total Capital	36.25	34.64	20.21	23.07	23.33
LT Debt/Equity	53.11	49.43	19.79	27.86	28.34
Long-Term Debt / Total Capital	33.86	32.31	15.79	21.43	21.73
Total Liabilities / Total Assets	47.34	46.38	32.69	33.84	34.55
EBIT / Interest Expense	16.42	19.88	18.55	9.73	7.48
EBITDA / Interest Expense	20.78	23.33	22.02	13.03	11.73
(EBITDA - Capex) / Interest Expense	14.5	16.41	16.17	6.09	5.97
Total Debt / EBITDA	2.38	1.82	1.16	2.1	1.92
Net Debt / EBITDA	2.1	1.6	0.56	1.59	1.46
Total Debt / (EBITDA - Capex)	3.42	2.58	1.58	4.48	3.77
Net Debt / (EBITDA - Capex)	3.02	2.27	0.76	3.39	2.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.91	35.91	10.57	-18.9	-3.92
Gross Profit, 1 Yr. Growth %	0.14	48.54	4.97	-25.93	0.53
EBITDA, 1 Yr. Growth %	-1.57	41.11	2.99	-37.34	-3.5
EBITA, 1 Yr. Growth %	-4.44	46.17	2.17	-43.32	-6.96
EBIT, 1 Yr. Growth %	-6.06	46.22	2.1	-43.44	-8.3
Earnings From Cont. Operations, 1 Yr. Growth %	-9.92	60.12	102.39	-73.66	-7.26
Net Income, 1 Yr. Growth %	-9.96	59.13	102.4	-73.66	-7.31
Normalized Net Income, 1 Yr. Growth %	-7.12	46.13	1.87	-44.06	-12.15
Diluted EPS Before Extra, 1 Yr. Growth %	-10.21	48.26	102.53	-73.69	-7.2
Accounts Receivable, 1 Yr. Growth %	35.59	16.31	13.41	1.08	-12.92
Inventory, 1 Yr. Growth %	12.53	46.4	4.74	-26.47	7.83
Net Property, Plant and Equip., 1 Yr. Growth %	15.21	9.7	-1.36	6.6	3.22
Total Assets, 1 Yr. Growth %	60.17	8.73	9.67	-0.91	-1.95
Tangible Book Value, 1 Yr. Growth %	-34.25	75.97	141.96	-18.79	2.96
Common Equity, 1 Yr. Growth %	84.16	10.56	37.88	-2.61	-2.98
Cash From Operations, 1 Yr. Growth %	-5.56	21.15	-11.36	9.51	-5.36
Capital Expenditures, 1 Yr. Growth %	9.32	33.04	-7.71	27.76	-1.11
Levered Free Cash Flow, 1 Yr. Growth %	-26.76	50.21	-41.31	-31.72	29.68
Unlevered Free Cash Flow, 1 Yr. Growth %	-24.84	47.09	-36.91	-25.74	28.15
Dividend Per Share, 1 Yr. Growth %	1.11	9.89	8	0.93	0.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.12	17.11	22.59	-5.3	-11.72
Gross Profit, 2 Yr. CAGR %	10.01	21.96	24.87	-11.82	-13.71
EBITDA, 2 Yr. CAGR %	-2.05	15.67	20.38	-19.67	-17.95
EBITA, 2 Yr. CAGR %	-3.47	15.6	22	-23.9	-22.3
EBIT, 2 Yr. CAGR %	-4.7	17.2	21.98	-24	-27.98
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.02	20.1	80.02	-26.98	-50.57
Net Income, 2 Yr. CAGR %	-8.06	19.7	79.46	-26.99	-50.59
Normalized Net Income, 2 Yr. CAGR %	-6.38	16.81	21.79	-24.51	-29.9
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.48	15.38	73.28	-27	-50.58
Accounts Receivable, 2 Yr. CAGR %	10.65	25.58	14.85	7.07	-6.18
Inventory, 2 Yr. CAGR %	2.65	28.35	23.83	-12.24	-10.96
Net Property, Plant and Equip., 2 Yr. CAGR %	12.12	12.42	4.02	2.55	4.9
Total Assets, 2 Yr. CAGR %	25.84	31.97	9.2	4.25	-1.43
Tangible Book Value, 2 Yr. CAGR %	-28.53	7.57	106.35	40.18	-8.56
Common Equity, 2 Yr. CAGR %	26.56	42.69	23.46	15.88	-2.79
Cash From Operations, 2 Yr. CAGR %	4.66	6.96	3.63	-1.48	1.8
Capital Expenditures, 2 Yr. CAGR %	7.13	20.6	10.81	8.59	12.4
Levered Free Cash Flow, 2 Yr. CAGR %	6.55	-1.79	-6.41	-36.7	20.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.02	-0.9	-3.95	-31.55	19.29
Dividend Per Share, 2 Yr. CAGR %	1.05	5.41	8.94	4.4	0.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.42	10.86	14.89	6.82	-4.84
Gross Profit, 3 Yr. CAGR %	6.9	21.59	16.01	4.92	-7.88
EBITDA, 3 Yr. CAGR %	-0.46	9.26	11.17	-3.17	-11.49
EBITA, 3 Yr. CAGR %	-1.31	9.23	10.81	-5.51	-14.88
EBIT, 3 Yr. CAGR %	-2.4	9.91	11.81	-5.59	-19.1
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.21	10.65	42.92	-5.14	-20.93
Net Income, 3 Yr. CAGR %	-5.25	10.39	42.6	-5.34	-20.94
Normalized Net Income, 3 Yr. CAGR %	-3.75	8.79	11.47	-6.04	-20.6
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.49	7.49	39.18	-7.55	-20.92
Accounts Receivable, 3 Yr. CAGR %	11.84	12.51	21.38	10.06	-0.06
Inventory, 3 Yr. CAGR %	5.39	15.54	19.94	4.08	-6
Net Property, Plant and Equip., 3 Yr. CAGR %	12.77	11.31	7.63	4.88	2.77
Total Assets, 3 Yr. CAGR %	22.48	19.86	24.07	5.72	2.14
Tangible Book Value, 3 Yr. CAGR %	-14.38	-3.49	40.94	51.22	26.48
Common Equity, 3 Yr. CAGR %	24.5	20.98	41.07	14.08	9.22
Cash From Operations, 3 Yr. CAGR %	3.02	9.89	0.47	5.55	-2.79
Capital Expenditures, 3 Yr. CAGR %	-9.63	15.15	10.31	16.19	5.25
Levered Free Cash Flow, 3 Yr. CAGR %	8.62	14.35	-17.46	-15.75	-5.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.94	15.09	-14.92	-11.85	-3.53
Dividend Per Share, 3 Yr. CAGR %	3.12	3.91	6.27	6.2	3.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.15	8.73	8.76	4.09	3.4
Gross Profit, 5 Yr. CAGR %	10.85	16.1	13.76	6.93	3.06
EBITDA, 5 Yr. CAGR %	4.63	8.75	6.6	-3.45	-1.55
EBITA, 5 Yr. CAGR %	3.95	8.95	6.48	-5.54	-3.86
EBIT, 5 Yr. CAGR %	3.06	9.19	6.71	-5.23	-6.23
Earnings From Cont. Operations, 5 Yr. CAGR %	2.17	10.31	22.51	-6.3	-6.54
Net Income, 5 Yr. CAGR %	2.21	10.28	22.33	-6.44	-6.68
Normalized Net Income, 5 Yr. CAGR %	2.24	8.54	5.86	-6.07	-7.41
Diluted EPS Before Extra, 5 Yr. CAGR %	1.98	8.81	20.44	-7.92	-8.02
Accounts Receivable, 5 Yr. CAGR %	13.03	11.59	13.03	10.3	9.5
Inventory, 5 Yr. CAGR %	6.43	13.45	12.41	3.51	6.47
Net Property, Plant and Equip., 5 Yr. CAGR %	16.32	12.46	9.19	7.72	6.53
Total Assets, 5 Yr. CAGR %	18.02	17.04	16.98	13.35	13.16
Tangible Book Value, 5 Yr. CAGR %	0.83	14.49	21.73	12.05	18.54
Common Equity, 5 Yr. CAGR %	21.45	23.92	24.08	18.91	21.54
Cash From Operations, 5 Yr. CAGR %	6.69	5.68	3.26	5.19	1
Capital Expenditures, 5 Yr. CAGR %	4.41	8.07	-1.95	12.48	11.14
Levered Free Cash Flow, 5 Yr. CAGR %	0.35	4.64	-0.32	-9.86	-4.03
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.56	5.65	1.72	-6.62	-2.6
Dividend Per Share, 5 Yr. CAGR %	4.45	5.7	5.41	4.11	4.1